Literature DB >> 625191

Effect of psychotropic drugs on 3,4-dihydroxyphenylacetic acid (DOPAC) content in the medial basal hypothalamus.

A Argiolas, E Paglietti, F Fadda, B P Quarantotti, G L Gessa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 625191     DOI： 10.1016/0024-3205(78)90425-3

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  5 in total

1.  Distribution of 3,4-dihydroxyphenylacetic acid (DOPAC) and 3,4-dihydroxyphenylglycol (DOPEG) in microdissected brain structures and the pituitary gland: metabolite changes in the median eminence in response to hyperprolactinemia and suckling.

Authors:  J I Mechanick; I R Cohen-Becker; K A Gregerson; M Selmanoff
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

Review 2.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

3.  Dopamine, noradrenaline and 3,4-dihydroxyphenylacetic acid (DOPAC) levels of individual brain nuclei, effects of haloperidol and pargyline.

Authors:  M I Fekete; J P Herman; B Kanyicska; M Palkovits
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

4.  Differential sensitivity of hypothalamic dopaminergic and noradrenergic neurones to pharmacological manipulation.

Authors:  F Karoum; S G Speciale; R J Wyatt
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

5.  Free and conjugated 3,4-dihydroxyphenylacetic acid and homovanillic acid in brain dopaminergic areas at basal state and after pipotiazine activation.

Authors:  E Tavitian; L Peyrin; Y Dalmaz; R Favre; M De Haut; J M Cottet-Emard
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.